AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

CRESCENT BIOPHARMA, INC. Director's Dealing 2016

Mar 21, 2016

33678_dirs_2016-03-21_6778e0b0-0761-4a18-a14b-5459ac8afa64.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: GLYCOMIMETICS INC (GLYC)
CIK: 0001253689
Period of Report: 2016-03-17

Reporting Person: JUNIUS DANIEL M (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities beneficially owned	0	Direct